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ABSTRACT
Balance is critical for optimal function in completion of everyday tasks. Physical
therapists frequently work with people that have balance disturbances in order to help
return them to optimal function. One tool used in the assessment and treatment of
balance disorders is the NeuroCom® Balance Master 7.06 (NBM), a computerized
forceplate system that provides objective measurements of balance performance. In order
to obtain accurate measurements on the NBM, it is necessary that the tester have
adequate training. The purpose of this study was to determine the amount of training
necessary for a therapist to obtain reliable results using the NBM. The study consisted of
11 healthy adult subjects who participated in six testing sessions each. Data was
collected and compared between test sessions to determine if results were reliable over
time. Results showed that clinical reliability (ICC> 0.90) was not reached or maintained
for all components of the Limits of Stability Test following familiarization and a
moderate level of tester training. However, data obtained for each component either met
or exceeded the level of intra-rater reliability found by the manufacturer. Because
clinical reliability was not reached by the conclusion of the study, researchers were not
able to determine the amount of training necessary to become clinically reliable with the
NBM.
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CHAPTER I
INTRODUCTION
Balance is critical for optimal function and completion of everyday tasks. l It is
necessary to have appropriate balance in order to get out of bed, ambulate and complete
other activities of daily living. Balance assessment and training are important
components of rehabilitation for patients with a wide variety of disorders including
orthopedic, neurologic, vestibular and geriatric diagnoses?.3
In order to accurately assess balance and measure progress of patients, a therapist
must be able to obtain reliable and valid measurements. Reliability is defined as the
extent to which a measuring tool produces the same results without significant error
across repeated testing sessions (intra-rater reliability) and between multiple raters (interrater reliability).4,5 Validity is defined by O'Sullivan and Schmitz6(p95) as "the degree to
which an instrument or tool measures what it is designed to measure; the degree to which
an assessment instrument or tool is able to predict future behavior."
The NeuroCom® Balance Master 7.06 (NBM) is one clinical measurement tool
commonly used in the assessment and treatment of balance disorders. The NBM is a
computerized forceplate system that provides objective measurements of balance
performance. Reliability of the Limits of Stability (LOS) Test, one of eleven assessments
available on the NBM, has been assessed by a small number of studies. 1,4,7,8 These
studies found moderate to high intra-rater reliability with some movement variables
1

representing the person's ability to voluntarily sway to different locations in space
quickly and accurately. However, none of the studies addressed the amount of training
necessary to reach intra-rater reliability.
Problem Statement
Although the NBM is commonly used in the assessment and treatment of balance
impairments in physical therapy settings, little research has been done to show the
amount of training necessary to obtain intra-rater reliability.4 Intra-rater reliability is
important in the clinical setting in order to determine the accuracy of assessments and
efficacy of therapeutic interventions performed on the NBM. A therapist must be reliable
in obtaining measurements so results can be compared across test sessions and changes in
performance can be documented. Thus, it is imperative to determine the amount of
experience needed in order to obtain reliable results.
Purpose/Research Question
The purpose of this study is to determine the amount of training needed for a
therapist to become reliable with the NBM for use in both clinical and research settings.
This study will attempt to answer the following question: Will a clinical level of intrarater reliability (ICC> 0.90) be reached in the NBM LOS Test with a moderate level of
tester training (35-42 test trials), including prior familiarization with the operation of the
NBM?
Hypothesis
It is hypothesized that intra-rater reliability will be reached in the NBM LOS Test

upon completion of moderate tester training, including prior familiarization in the

2

operation of the NBM.

The null hypothesis is: Intra-rater reliability cannot be achieved

within 35-42 testing sessions.
Significance
Balance is a necessary component that enables individuals to participate in and
safely complete a variety of everyday activities. Physical therapists assess and treat
people with balance disturbances using the NBM in order to help return them to optimal
function. As a result, it is necessary to determine the amount of training needed to obtain
intra-rater reliability on the NBM. This will allow for objective, measurable and reliable
documentation in the clinic and in future research, enabling physical therapists to provide
more accurate balance assessment and training for their patients. The client will also be
able to obtain reliable, understandable feedback concerning his or her progress.

3

CHAPTER II
LITERATURE REVIEW
Balance, or postural control, is an important component necessary for everyday
function. Nichols 9(p553) defines balance as "the ability to maintain or move within a
weight-bearing posture without falling." Balance is composed of components from three
systems: visual, vestibular and somatosensory.6,IO-12 In order to process, integrate and
respond to information from all three systems an intact central nervous system is
necessary. 10, 11 The three systems work together with the central nervous system to
achieve the overall goals of balance: safety and function. 6
If a problem with balance arises that jeopardizes a person's safety or function, a

balance assessment may be performed to determine the source of the problem. There are
three aspects of balance that are frequently measured during balance assessment:
steadiness or static balance, symmetry and dynamic stability.7,9 Steadiness or static
balance is the ability to maintain a certain posture with a minimal amount of sway on a
stable surface. 9,13 There are many assessments used to test static balance, some examples
include the Romberg Balance Test and One-legged Stance Test. 14 Symmetry is described
as the ability to distribute weight evenly between the two sides of the body in an upright
stance. 7,9 Symmetry can be assessed using two standard scales or the Weight Bearing
Test on the NBM. Dynamic stability is defined as the ability to move the center of
gravity (COG) around the base of support (BOS) without a loss of balance. There are
4

several assessment tools used to analyze dynamic stability including the Berg Balance
Measure, the Tinetti Assessment Tool, and the NBM LOS Test. 1,3,4
Limits of Stability
Limits of stability are defined in the NBM Operator's Manual as "the maximum
distance a person can lean in a given direction (measured as angular distance from
vertical) without losing balance, stepping, or reaching.,,2(pLOS-5) In the average, healthy
adult LOS in standing encompasses 12 degrees from anterior to posterior and 16 degrees
from side to side. 3,6,15,16 Limits of stability are variable and can be affected by the task
being performed, the individual's biomechanics and various components of the
environment. 10
BalancelPostural Strategies
As a person displaces his or her COG to reach the LOS, specific automatic
postural synergies are used to maintain balance.6,1O,11 ,15 Postural synergies are patterns of
leg and trunk muscle contractions used to preserve standing balance. These strategies
include ankle, hip and stepping strategies. The ankle strategy is the first strategy utilized
to maintain balance when there is a small disturbance within the LOS. The body is
shifted forward and backward around the ankles as a rigid unit. Muscular activation
occurs in a distal to proximal pattern of response. This strategy is the most effective
strategy with small perturbations on a firm surface.
The hip strategy is utilized with larger disturbances of balance or to maintain
balance on varied surfaces.6,10,11 ,15 It involves shifting the COG by flexing and extending
the hips with a proximal to distal muscle activation pattern. This strategy moves the
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COG more quickly as compared to the ankle strategy so it is more effective with large
disturbances to balance and on a wider variety of surfaces.
The stepping strategy involves the use of rapid steps to maintain balance in
response to fast, large postural perturbations. 6,IQ,II ,15 This strategy is utilized when the
LOS are exceeded and the ankle and hip strategies are no longer sufficient to maintain the
COG over the BOS . Although described as separate strategies, the ankle, hip and
stepping strategies are used in combination in response to perturbations that may
jeopardize balance. It has been found that the processes involved in balance control vary
with different task requirements and are task specific. I
Balance Assessment Tools
A number of tools can be utilized in the development of a balance training
program including functional assessment scales (such as the Berg Balance Measure and
Tinetti Assessment Tool), and the NMB . I,3,4 The Berg Balance Measure is a functionally
based balance assessment developed for use in the elderly and neurologically impaired
individuals. It is considered the "gold standard" of balance assessments and consists of

14 items graded from 0 to 4 including transfers, standing in various conditions and
reaching with a maximum score of 56 points. The Berg Balance Measure has been
shown to be reliable and correlates well with other balance tests. I The Tinetti
Assessment Tool is a balance and mobility test, which consists of 18 items graded for a
maximum of 28 points. This tool is composed of two subscales assessing both gait and
balance. The Tinetti Assessment tool has also shown reliability and validity in testing
balance and predicting falls in the elderly.IQ,17
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Computerized balance measures have been utilized in the research setting for
several decades but have become more prevalent in the clinical setting in recent years. 1.3,4
One of the main benefits of computerized technology is that it allows therapists to
quickly and reliably obtain objective, quantifiable balance measurements. It also enables
the therapist to objectively evaluate a patients' initial status and subsequent progress. 1.3,4
This allows for increased sensitivity in measurement of balance compared to traditional
measurement tools, reSUlting in more accurate and quantifiable results.
NeuroCom Balance MasterlLimits of Stability Test
The NBM is one example of a commonly used computerized form of balance
assessment and training. 2•3 This system is an instrument designed to provide objective,
quantitative measurements of static and dynamic balance performance. Forceplate
technology is utilized to determine COG excursion adjusted for the height of the subject
being tested.2•3 Static and dynamic balance testing can be used to analyze the subjects'
COG movements.
The NBM has the capability to objectively measure dynamic standing balance
through the use of the LOS Test? The LOS Test is used to assess the subjects' control of
direction, accuracy and speed of COG movements while weight shifting toward
predetelmined targets representing 100% of the theoretical LOS. To perform a variety of
standing functional activities, the speed, direction, and distance of COG movement must
be controlled. The LOS Test measures all three of these, making it an accurate measure
of functional balance. I The following five components are calculated with this test:
reaction time (RT), movement velocity (MVL), endpoint excursion (EPE), maximum
excursion (MXE), and directional control (DCL). These will be defined in Chapter III.
7

The NBM has been shown to be reliable and valid for testing balance. Liston et
all compared six assessments on the NBM to the Berg Balance Scale and the Gait
Velocity Test, two reliable and valid balance tests used in the physical therapy setting.
The results of these comparisons show a strong correlation between the NBM
assessments and the Berg Balance Scale and Gait Velocity Test with dynamic balance
testing, including the LOS assessmen.t.
Reliability is defined as the extent to which a measuring tool produces the same
results without significant error across repeated testing sessions and/or between mUltiple
raters. 4,5 Reliability can be divided into two types: intra-rater and inter-rater. Intra-rater
reliability is defined as reliability across repeated testing sessions for a single rater and
inter-rater reliability is defined as reliability between multiple raters. It is necessary to
establish intra-rater reliability with any procedure prior to finding inter-rater reliability.
In establishing intra-rater reliability, some degree of variability should be
expected; however this variability should not be statistically significant. 4 Previous
studies on the NBM have used composite scores in the determination of intra-rater
reliability.I,4,8 Composite scores are computed by taking the average of all eight direction
scores. In a study by Rose 8, 176 healthy subjects ages 20-79 were assessed using the
NBM version 6.1 of the LOS Test. The study found that intra-rater reliability ranged
from R =0.68 to R

=0.80 for the five components.

4
A study done by Clark et al used 38

community dwelling older adults to establish the reliability of the LOS Test using the Pro
Balance Master version 5.0b. Intra-rater reliability for MVL, MXE, EPE and DCL
ranged from Generalizability (G) =0.57 to 0.91. Liston et all conducted a study on 20
ambulatory hemiparetic subjects to determine intra-rater reliability of the Balance Master.

8

This study found ICC =0.84 for DCL and ICC =0.88 for RT and MVL, but did not
report values for MXE or EPE.
Although the above research has shown moderate to high intra-rater reliability
with some components of the LOS test, no research has shown intra-rater reliability with
all of the components. Furthermore, this research has not addressed the amount of
training necessary to obtain intra-rater reliability using the NBM to assess balance.

9

CHAPTERID
METHODOLOGY
Prior to beginning this study, approval for the use of human subjects was obtained
from the University of North Dakota's Institutional Review Board. A copy of the Human
Subjects Review Form and the approval letter are located in Appendix A. During the
process of subject recruitment, all individuals were informed that participation in this
study was voluntary. The study was explained in detail to interested subjects and each
individual signed a consent form prior to participation. A copy of this consent form can
be found in Appendix B. In order to address any safety or health concerns associated
with testing on the NBM, subjects were asked to complete a health background
questionnaire prior to inclusion in the study. Questions were related to past medical
history, medications, current symptoms, presence of a diagnosed psychological condition,
number of falls, vision and previous testing on the NBM. Prior to each testing session,
subjects were required to complete a current health status questionnaire to determine if
any events had occurred that may have affected balance. Copies of these questionnaires
are located in Appendix C.
Subjects
Participants in this study were recruited by word of mouth from the Grand Forks
community and the University of North Dakota population. Inclusion criteria determined
by the health background questionnaire were as follows:

10

1. Ages 20-59
2. No previous history of balance deficits
3. No unexplained falls within the last six months
4. No current medications that affect balance
5. No injuries or surgeries that may have affected balance

6. No prior testing or experience with the NBM.
Eleven subjects met the above criteria and were selected to participate in testing on the
NBM. Subjects were tested six times with 3-7 days between testing sessions.
Instrumentation
The NBM version 7.06 (NeuroCom International Inc., 9570 SE Lawnfield Road,
Clackamas, OR 97015-9611) is a clinically acceptable and safe machine commonly used
in physical therapy in the evaluation and treatment of balance issues in a wide variety of
patients.z,6,11,16,17 The NBM has been shown to be a reliable and valid instrument as
discussed in Chapter II. It consists of two 9" x 60" forceplates on which the subject
stands to measure forces from the subject's feet. These forceplates rest on four load cells
that relay information to a computer software system that interprets the data obtained
during a balance assessment. The computer then displays the data as visual feedback on
the screen, which provides the subject with information about the location of his or her
COO. See Figure 1 for a picture of the NBM.
A variety of balance assessment and training options are available on the NBM.
One assessment option is the LOS Test which measures the subject's ability to weight
shift forward, backward, left, right and diagonally and briefly maintain stability at eight

11

predetennined positions as shown in Figure 2? These positions represent 100% ofthe
theoretical LOS.

Figure 1. The NeuroCom Balance Master.

•
Figure 2. Eight targets for the Limits
of Stability Test.
The LOS Test on the NBM consists of five components including reaction time,
movement velocity, endpoint excursion, maximum excursion, and directional control?
The definitions, as found in the NBM Operator's Manual, are as follows:
12

1. Reaction time - the time in seconds between the signal to move and the
initiation of movement
2. Movement velocity - the average speed of COG movement expressed in
degrees per second between 5% and 95% of the distance to the primary
endpoint
3. Endpoint excursion - the distance traveled by the COG on the primary attempt
to reach the target expressed in percent of LOS
4. Maximum excursion - the furthest distance traveled by the COG during the
trial
5. Directional control- comparison of the amount of movement in the intended
direction (toward the target) to the amount of extraneous movement (away
from the target).
During the LOS test, the subject's COG is represented on the computer screen by
a cursOr. 2,8 This provides the subject with immediate feedback on his or her performance.
Following each test, the computer generates a printout consisting of scores for the above
five components of balance. An example of a printout can be found in Appendix D.
Composite scores for each of the balance components were used to assess intra-rater
reliability.
Researcher Training
Prior to beginning this study, the researchers became familiar with the NBM by
reading the operator manual and administering each of the eleven NBM tests to one
subject. This allowed the researchers to gain general knowledge about the machine and
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how it operates. The researchers did not operate the NBM for three months following
familiarization.
Assessment Procedure
Subject testing took place at the University of North Dakota Physical Therapy
Research Lab. The same two researchers were present for all testing sessions. One of the
testers was responsible for instructing the subjects, while the other was responsible for
spotting the subjects to ensure safety and to prevent falls and/or injury during testing.
One researcher was assigned six subjects to assess LOS while the other was assigned five
subjects. These assignments were consistent throughout all testing trials.
The NBM is self-calibrating; however, calibration was verified during each
system initialization to ensure the accuracy of forceplate readings. Subjects then
completed the consent form and health background questionnaire. Following completion
of these forms, subjects' height, date of birth and an identification letter were entered into
his or her computer file. Subjects were tested barefoot to minimize variability due to
traction and shoe height. Their feet were aligned on the forceplate according to
instructions given on the computer screen. Figure 3 below shows the guide for proper
foot placement, which includes alignment of the medial malleolus with the wide blue line
on the forceplate and placement of the lateral calcaneous on the "M" or "T" line
according to subject height. This same foot placement was utilized during all subsequent
testing sessions.
To reduce practice effects and maximize subject familiarity with the test, subjects
were allowed to practice weight shifting and moving the cursor to the different targets for
up to five minutes or until they became familiar with the requirements of the test. 8
14

Subjects were allowed to move their arms and shift their hips but could not lift their heels
from the forceplate. Once the subject was comfortable with the machine, a researcher
read a prewritten set of instructions to the subject. This ensured all subjects were given
the same set of instructions independent of the tester. A copy ofthese instructions can be
found in Appendix E.
,.
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Figure 3. Forceplate landmarks for
proper foot alignment.
At the initial assessment, subjects were required to complete two LOS
assessments. Data from the first assessment was not used in statistical analysis due to the
high learning curve shown between the first and second trials. Clark et al 4 found
significant differences in scores on the LOS test from the first assessment to the second
assessment, but no significant differences between trials two, three, and four.
Immediately following instruction, subjects completed the first LOS assessment. They
were given a rest period of up to five minutes. Subjects were then allowed to complete a
second LOS assessment test following the above procedure.
At each of the five subsequent testing sessions scheduled 3-7 days apart, the
subjects were required to complete a current health status questionnaire. Subjects were
15

aligned on the platfonn, given up to five minutes of practice time, read the instructions
and then allowed to complete one LOS assessment.
Data Analysis
The data gathered from the subjects' LOS trials two through seven was entered
into the SPSS Version 10.0 software system. The data from trial one was discarded to
account for the high learning curve found between trials one and two, as previously
discussed. The descriptive statistics perfonned by this program included the mean and
standard deviation. Comparisons were made between the different trials using the
Pearson correlation coefficient (r) and ICC.
Intraclass correlation coefficient has no absolute standard for acceptable
reliability. The ICC values range between 0.00 and 1.00, with stronger reliability
indicated when the numbers fall close to 1.00. 18 The researcher determines the ICC
values needed to obtain reliability for each study. As a general guideline, values above
0.75 represent good reliability whereas those below 0.75 are indicative of poor to
moderate reliability. 19 In order to meet clinical reliability the ICC values should exceed
0.90. Table 1 outlines the ICC value interpretation for intra-rater reliability.

Table 1. Intraclass Correlation Coefficient Value Interpretation
ICC Value
0.90-1.00
0.75-0.90
<0.75

Interpretation
High
Good
Poor to Moderate

The Pearson correlation coefficient (r) measures the degree and direction of a
relationship between two variables. The r value may range from -1.00 to 1.00. A perfect
positive relationship is represented by an r value of 1.00, no relationship is represented by
16

an r value of 0.00, and a perfect negative relationship is represented by an r value of

-l.oo?O

The direction (positive or negative) does not affect the strength of the

relationship; therefore, Table 2 represents positive and negative r values.21 A common
interpretation of r values are listed in Table 2. These parameters were then used for
further analysis in determining the intra-rater reliability for the LOS assessment with the
NBM.

Table 2. Pearson Correlation Coefficient Value Interpretation
r value
0.90-1.00
0.70-0.89
0.50-0.69
0.26-0.49
0.00-0.25

Interpretation
Very High
High
Moderate
Low
Little to Zero
Reporting Results

Upon completion of this study, a copy of the results of this scholarly project was
given to both the preceptor of this project and the University of North Dakota Health
Sciences Library. This study was completed to fulfill the requirements of the University
of North Dakota School of Medicine and Health Sciences Physical Therapy Program.
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CHAPTER IV
RESULTS
Results from this study consisted of measures from the NBM LOS Test. The data
obtained from six separate trials were analyzed using descriptive statistics and then later
compared utilizing Pearson correlation coefficient and ICC. Trials were compared in
pairs (i.e., trial 1 and trial 2, trial 2 and trial 3, etc.) to determine at what point the testers
reached intra-rater reliability on the NBM LOS Test.
Subject Profile
A total of eleven subjects participated in this study consisting of four females and
seven males with ages ranging from 20 to 45 years old. The mean calculated age was
29.4 with a standard deviation of 9.6. Subjects were randomly assigned to one of the two
testers. Subjects assigned to Tester 1 and Tester 2 had a mean age of 33.4 and 26.3
respectively. The subjects were required to return for six testing sessions over a threeweek period. All subjects completed a health status questionnaire and no significant past
medical histories were reported that would require exclusion from the study.
Research Questions
The purpose of this study was to determine if a clinical level of intra-rater
reliability would be reached in the NBM LOS Test with a moderate level of tester
training (35-42 test trials), including prior familiarization with the operation of the NBM.
Clinical reliability was obtained if the ICC values were equal to or greater than 0.90.
18

This study investigated the reliability of each of the components of the NBM LOS Test.
The results from each component are discussed separately. The Pearson correlation
coefficient determined the relationship between trials, established the degree of
correlation, and enabled researchers to make predictions. An ICC value determined the
level of tester reliability on the LOS Test. The values used to determine the degree of
correlations and reliability are presented in Tables 1 and 2 of Chapter III. Statistics
reported for all components of the LOS Test include the mean, standard deviation,
Pearson correlation coefficient and ICC.
Reaction Time (RT)
Reaction time results for Tester 1 and Tester 2 are reported in Table 3. According
to the ICC value interpretation, Tester 1 did not reach clinical reliability (ICC> 0.90) by
the sixth trial. However, the tester's reliability improved when comparing trials 1-6, and
Pearson correlation coefficient values indicated a very high correlation between trials 4
and 5 and trials 5 and 6. A negative ICC was calculated when comparing trials 1 and 2.
Normally, values from ICC data range from 0.00-1.00 therefore it cannot be interpreted.
The degree of variability for each subject between trials is shown in Figure 4. The lines
of the graph represent the actual RT scores for each subject tested by Tester 1. The
subjects did not demonstrate enough consistency between trials to reach reliability for
Tester 1 on the RT component. A high degree of reliability would have been indicated
by horizontal lines, instead there is a great deal of variability noted by the crossing of the
lines and the change in slope. The largest amount of variability was noted between trials
1 and 2 but the amount of variability decreased and the lines straightened for most of the
subjects by trial 4. This coincides with the higher ICC values found for trials 4 and 5 and
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Table 3. Results for Reaction Time in Seconds for Tester 1 and Tester 2

N

o

Trial
1
2
2
3
3
4
4
5
5
6

n

4
4
4
4
4
4
4
4
4
4

x
.9220
.7900
.7900
.8760
.8760
.8400
.8400
.8540
.8540
.7960

Tester 1
SD
.1486
.2650
.2650
.1284
.1284
.2260
.2260
.2880
.2880
.1872

r

-.3903

ICC
invalid

.6848

.5373

.5792

.5036

.9202

.8884

.9549

.8728

Trial
1
2
2
3
3
4
4
5
5
6

n

5
5
5
5
5
5
5
5
5
5

x
.6817
.7000
.7000
.6500
.6500
.7083
.7083
.6217
.6217
.6900

Tester 2
SD
.0933
.1752
.1752
.1825
.1825
.2363
.2363
.1554
.1554
.1912

r

ICC

.7089

.5882

.8933

.8925

.8751

.8468

.9803

.9001

.9257

.9061

trials 5 and 6. Graphs for all the LOS Test components for both Tester 1 and Tester 2
can be found in Appendix F.
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Figure 4. Actual reaction time values in seconds for subjects tested by Tester 1.
Tester 2 demonstrated clinical reliability between trials 4 and 5 and trials 5 and 6,
according to the ICC interpretation with values greater than 0.90. In addition, good
reliability was found between trials 2 and 3 and trials 3 and 4. The Pearson correlation
coefficient displayed moderate correlation between trials 1 and 2, high correlations
between trials 2 and 3, and trials 3 and 4, and very high between ttials 4 and 5 and trials 5
and 6.
Movement Velocity (MVL)
Results for MVL for both Tester 1 and Tester 2 are reported in Table 4. Tester 1
reached clinical reliability on the MVL component between trials 4 and 5 and trials 5 and
6, when examining ICC values. On the previous trials, Tester 1 produced varying results
from good (ICC = 0.75-0.90) to poor/moderate (ICC < 0.75) reliability according to the
ICC interpretation. When comparing these results to the Pearson correlation
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Table 4. Results for Movement Velocity in Degrees Per Second for Tester 1 and Tester 2

tv
tv

Trial
1
2
2
3
3
4
4
5
5
6

n
4
4
4
4
4
4
4
4
4
4

x

4.920
5.220
5.220
5.620
5.620
5.540
5.540
5.700
5.700
5.700

Tester 1
SD
1.1520
1.2677
1.2677
.8106
.8106
1.6087
1.6087
1.6000
1.6000
1.1979

r

ICC

.7563

.7520

.5567

.5053

.4785

.3846

.9557

.9557

.9391

.9011

Trial
1
2
2
3
3
4
4
5
5
6

n
5
5
5
5
5
5
5
5
5
5

Tester 2
SD
5.5333
1.7705
5.9000
2.1485
5.9000
2.1485
5.9167
2.4959
5.9167
2.4959
6.5500
1.9655
6.5500
1.9655
5.8833
1.5993
5.8833
1.5993
5.8833
1.8357
x

r

ICC

.8823

.8660

.9787

.9678

.9424

.9161

.9363

.9167

.8883

.8799

interpretation tables, the correlation was considered to be high for trials 1 and 2, moderate
for trials 2 and 3, low for trails 3 and 4, the remaining trails were found to be very high.
These results show a great deal of variability during the first three comparisons but the
individual scores become more consistent during trials 4-6 enabling the Tester 1 to reach
clinical reliability.
Tester 2 was found to be clinically reliable between trials 2 and 3, trials 3 and 4,
and trials 4 and 5, with all ICC values above 0.90. Clinical reliability was not obtained
on trials 1 and 2 and trials 5 and 6; however, reliability was good according to ICC
interpretation. A very high Pearson correlation coefficient was determined for the trials
corresponding with those found to be clinically reliable and high correlation was found
for the good ICC values.
Endpoint Excursion (EPE)
Results for endpoint excursion for Tester 1 and Tester 2 are illustrated in Table 5.
Tester 1 found clinical reliability between trials 1 and 2; however, EPE was not reliable
for the remaining trials. Trials 2 and 3 and trials 5 and 6 were found to have
poor/moderate reliability; the other trials demonstrated good reliability. The Pearson
correlation coefficients also varied between trials (moderate to high) with only trials 1
and 2 displaying a very high correlation.
Tester 2 did not reach clinical reliability by the sixth trial. Good reliability was
obtained for all of the trials according to ICC interpretation (0.75-0.90). High correlation
values for the Pearson correlation coefficient was also found for trials 1-6.
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Table 5. Results for Endpoint Excursion in Percentage of Normative Data for Tester 1 and Tester 2

~

Trial
1
2
2
3
3
4
4
5
5
6

n

4
4
4
4
4
4
4
4
4
4

Tester 1
x
SD
90.0000
8.4558
93.4000
7.0214
93.4000
7.0214
7.4027
91.6000
7.4027
91.6000
89.6000
6.6558
89.6000
6.6558
88.0000
7.3485
88.0000
7.3485
4.0988
90.4000

r

ICC

.9390

.9230

.6436

.6427

.7621

.7578

.8894

.8850

.8051

.6850

Trial
1
2
2
3
3
4
4
5
5
6

n

5
5
5
5
5
5
5
5
5
5

Tester 2
x
SD
78.3333
8.2138
80.8333 10.2453
80.8333 10.2453
82.5000 10.8028
82.5000 10.8028
85.0000 10.3344
85.0000 10.3344
82.1667
9.3684
82.1667
9.3684
83.0000 10.5071

r

ICC

.8469

.8266

.7852

.7842

.8778

.8770

.8656

.8614

.8208

.8155

Maximum Excursion (MXE)
Results for Tester 1 and Tester 2 are reported in Table 6. Tester 1 did not reach
clinical reliability with the MXE component on any of the six trials. The lowest
reliability was found between trials 5 and 6; the highest was shown between trials 1 and
2. Values ranged from poor/moderate reliability to high reliability according to the ICC
value interpretation table. Pearson correlation coefficients were also demonstrated a
great amount of variation with the lowest values found between trials 5 and 6 indicating a
moderate correlation and the highest value found between trials 4 and 5 indicating a high
correlation.
Tester 2 also did not meet clinical reliability on the MXE component during
testing. Tester 2 showed good ICC values between trials 2 and 3, trials 4 and 5, and trials
5 and 6. The other trials were categorized with poor/moderate reliability. Pearson
correlation coefficients were all considered to be high correlations.
Directional Control (DCL)
Results for the DCL component for Tester 1 and Tester 2 are reported in Table 7.
A negative ICC value was found when comparing trials 1 and 2 for Tester 1. This value
was unable to be interpreted. Clinical reliability was reached by Tester 1 between trials 4
and 5, but was not found between the remaining trials. The remaining trials, except for
trials 1 and 2 were found to have a good reliability according to the ICC interpretation
table. Pearson correlation coefficient values indicate a negative relationship between
trials 1 and 2, but high to very high positive correlations were found between the
remaining trials with values ranging between 0.72-0.95.
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Table 6. Results for Maximum Excursion in Percentage of Normative Data for Tester 1 and Tester 2

Trial
1
2
2
3
3
4
4
5
5
6

n
4
4
4
4
4
4
4
4
4
4

Tester 1
x
SD
98.8000
6.3008
97.8000
6.7397
97.8000
6.7397
97.4000
5.4589
97.4000
5.4589
97.6000
6.6558
97.6000
6.6558
95.2000
5.8052
95.2000
5.8052
98.2000
4.4944

r

ICC

.8819

.8818

.6489

.6411

.7899

.7746

.8825

.8744

.5347

.5176

Trial
1
2
2
3
3
4
4
5
5
6

n
5
5
5
5
5
5
5
5
5
5

Tester 2
x
SD
91.0000
2.8284
6.8702
92.0000
92.0000
6.8702
92.1667
7.4409
92.1667
7.4409
93.0000
6.0032
93.0000
6.0032
91.1667
5.1929
5.1929
91.1667
92.3333
7.1746

r

ICC

.7616

.5362

.8372

.8346

.7039

.6887

.8746

.8648

.8142

.7735

r

ICC

.8624

.8534

.8259

.7966

.8930

.8309

.9287

.8986

.9823

.9691

N

0\

Table 7. Results for Directional Control in Percentage of Normative Data for Tester 1 and Tester 2

Trial
1
2
2
3
3
4
4
5
5
6
-- - -

n
4
4
4
4
4
4
4
4
4
4

Tester 1
x
SD
84.000
2.5495
83.800
2.6833
8.3800
2.6833
83.400
2.6077
2.6077
83.400
84.600
4.1593
84.600
4.1593
4.0373
85.400
85.400
4.0373
2.8284
85.000

r

ICC

-.2193

invalid

.8003

.8000

.8021

.7220

.9498

.9494

.8319

.7819

Trial
1
2
2
3
3
4
4
5
5
6

n
5
5
5
5
5
5
5
5
5
5

Tester 2
x
SD
81.5000
5.5408
4.7924
80.1667
80.1667
4.7924
81.6667
6.2823
6.2823
81.6667
83.5000
4.2778
83.5000
4.2778
81.6667
5.5377
81.6667
5.5377
81.3333
6.5320

Tester 2 found good reliability for trials 1 and 2 but there was a slight decrease in
values in trials 2 and 3 (0.85-0.80). Reliability showed improvement beginning with
trials 2 and 3, and reached clinical reliabili ty between trials 5 and 6. Between trials 1-4,
the Pearson correlation coefficient displayed high values, and between the remaining
trials, the correlation became very high indicating a greater relationship between trial
values, which is a significant predictor of reliability.
Summary of Reliability for Each Component
The amount of reliability for each component of the LOS Test is shown in Table
8. The table displays ICC values for both Tester 1 and Tester 2. The lowest and highest
ICC values are reported for each component. The asterisks located in the RT and DeL
components for Tester 1 indicate negative values were obtained and the invalid numbers
were not included in the table.

Table 8. High and Low ICC Values for Each Component of the LOS Test for Both
Tester 1 and Tester 2
Tester 1

*

Tester 2
.5882 - .9061

Reaction Time

.5036 - .8884

Movement Velocity

.3846 - .9557

.8660 - .9678

Endpoint Excursion

.6427 - .9230

.7841 - .8770

Maximum Excursion

.5176 - .8744

.5362 - .8648

Directional Control

.7220 - .9494

*

.8309 - .9691

* IndIcates mvahd value obtamed
Time for Trial Testing
Each trial was timed throughout testing on the NBM. As a result, it was
discovered that the testers and subjects became more efficient in the testing procedure.
This data is presented in Table 9 and Table 10.
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Table 9. Time in min:sec for Subjects Tested by Tester 1
Subjects

Trial 1

Trial 2

Trial 3

Trial 4

A
D
E

3:25
4:15
3:56
3:05
4:16

4:06
3:30
3:19
3:05
3:32

3:15
3:31
2:57
3:01
4:25

3:03
2:59
3:08
3:04
3:09

G
I

TrialS
2:58
3:00
2:57
3:00
3:44

Trial 6

TrialS
3:10
3:15
3:07
3:10
3:03
3:50

Trial 6

2:58
3:00
3:07
2:57
3:09

Table 10. Time in min:sec for Subjects Tested by Tester 2
Subjects

Trial 1

Trial 2

Trial 3

Trial 4

B
C

3:38
3:32
3:22
3:15
3:16
4:45

3:15
3:14
3:11
3:55
3:46
4:05

3:16
3:46
3:08
3:08
3:11
4:00

3:11
3:10
3:07
3:06
3:10
4:10

F
H
J
K
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3:12
3:06
3:09
3:08
3:03
3:10

CHAPTER V
DISCUSSION
Balance is a critical component for proper functioning in everyday activities. In
order for a clinician to properly assess balance, results must be valid and reliable. The
use of computerized assessment can identify balance disorders, but ultimately the results
and measurements will depend on the reliability.4 Few studies have been performed to
establish the reliability of the NBM with little or no research in the amount of training
necessary to achieve clinical intra-rater reliability. 1,4,7 The results of this study show that
a clinical level of intra-rater reliability was not reached or maintained on all components
of the LOS Test on the NBM following prior familiarization and a moderate level of
tester training.
Throughout the discussion, results are interpreted and conclusions are drawn
based on the data collected. Values for ICC are reported for Tester 1 and Tester 2 and are
examined for clinical reliability. Also, Pearson correlation coefficients are reported and
compared to a study by Rose 8 that developed a database to look at intra-rater reliability
for the NBM LOS Test.
Within the NBM operator's manual the study performed by Rose8 is utilized to
prove that the LOS Test produces reliable values. However, they use different
correlation coefficient interpretation scales for predicting the amount of reliability.
According to Rose, a correlation coefficient greater than 0.80 is considered high, 0.80-
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0.60 is moderate, and less than 0.60 is poor. In a study performed by Rose, correlation
coefficient values for all components of the LOS Test, except movement velocity (MVL),
only achieved the moderate category for reliability. The only value that reached the high
category for reliability was MVL with a borderline value of 0.80. Even though her scores
have not reached clinical reliability, the NBM utilizes her study as proof of their LOS
Test reliability. However, Rose recognizes the limitations in her study of LOS Test
reliability.
Reaction Time (RT)
The LOS RT component measures the time between the signal to move and the
initiation of movement. 2 Tester 1 was unable to obtain values greater than 0.90, and
when comparing trial 1 and 2, a negative number was calculated which makes the value
invalid. This resulted because the analysis typically used for intra-rater reliability cannot
be performed on a closely clustered group of values. 8 If the differences between the
subjects is small, then poor reliability is indicated by the ICC scores, despite minimal
differences in the tester's measurements. 18 Overall, Tester 1 was inconsistent in
reliability values and at this point cannot be considered reliable with testing the RT
component on the NBM.
Tester 2 was found clinically reliable when comparing trial 4 to 5 and 5 to 6 with
ICC values of 0.90 and 0.91, respectively. Tester 2 had one more subject in her group
than Tester 1, which may have enabled her to reach reliable values at earlier trials. Tester
2 completed seven more training trials when compared to Tester 1,42 trials versus 35
trials. One source of error resulting in increased variability between repeated trials can
be attributed to the misunderstanding of directions by the subjects. 4 The instructions
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were structured prior to testing, and it was decided that they remain the same throughout
the study. However, subjects reported difficulty waiting for the blue circle to appear
prior to initiating movement. This aspect measures reaction time, and misunderstood
instructions may have altered the collected data.
When reviewing the RT component in the study done by Rose 8 , a correlation
coefficient of 0.74 was reported, indicating moderate reliability. In her study, only two
trials were used to calculate the correlation coefficients, whereas six trials were
performed in the present study to ensure proper reliability results. When comparing the
present study to Rose's, higher correlation coefficient values were produced for the RT
component (0.98 vs. 0.74).
Movement Velocity (MVL)
Movement velocity is the average speed of COG movement expressed in degrees
per second between 5% and 95% of the distance to the primary endpoint. 2 Tester 1 was
found to have clinical reliability on the MVL component between trials 4 and 5 and trials
5 and 6. It is difficult to determine if reliability can be maintained since previous trials
produced inconsistent values. Tester 1 demonstrated a gradual worsening prior to
obtaining a reliable measure, beginning with an ICC of 0.75 between trial 1 and 2 and
regressing to an ICC of 0.38 between trial 3 and 4. Although some degree of
inconsistency in reliability testing should be expected, the extent of differences between
values should not be statistically significant. 4 An expected gradual increase in reliability
values was anticipated, however the trials of Tester 1 demonstrated differences as great as
0.57 when comparing subsequent trials, indicating further testing may be necessary to
confirm results.
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Tester 2 was found to be clinically reliable between trials 2 and 3, trials 3 and 4,
and trials 4 and 5. Overall, the ICC values obtained by Tester 2 were above 0.87 falling
in the good to high categories according to the ICC interpretation table. The decrease in
the ICC value below 0.90 between trial 5 and 6 may be explained by a reduction in
motivation of the subjects. After seven trials, subjects reported testing protocols to be
monotonous and felt they did not put forth the effort that was experienced in previous
trials.
According to the study by Roses, the only component to reach high reliability
with a correlation coefficient value of 0.80 on the NBM LOS Test was MVL.
Correlation coefficients were high for Tester 1 and Tester 2 with values as high as 0.98,
greater than those discovered and reported by Rose.
Endpoint Excursion (EPE)
The EPE component, measuring the distance traveled by the COG on the primary
attempt to reach the target, for Tester 1 was found to be unreliable? Clinical reliability
was obtained between trials 1 and 2, however ICC values dropped below 0.90 for the
remaining trials and were unpredictable. Brouwer et al 3 states that LOS beyond 75%
causes subjects to elicit undesirable responses that reduces the ability to control their
COG. The LOS Test is programmed at 100% of the subject's LOS, a predefined setting
calculated from normative data. This may have required the subjects to utilize
undesirable responses in an attempt to reach the target resulting in inconsistency of the
EPE values.
Tester 2, also facing these similar problems, never reached clinical reliability on
the EPE component. Values did range in the good category according to the ICC
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interpretation table with values ranging from 0.78 to 0.88. Rose 8 found EPE to be the
second least reliable component, only achieving moderate reliability at 0.73, whereas in
the present study correlation coefficients were found to be as high as 0.94.
Maximal Excursion (MXE)
Tester 1 and Tester 2 did not obtain clinical reliability on the MXE component,
which is the furthest distance traveled by the COG? For both testers, reliability values
fluctuated and there was no predictable pattern between trials. Rose 8 reported a
correlation coefficient of 0.76 indicating moderate reliability, which is similar to the
average correlation coefficient in this study (0.77). However, correlation coefficients
reached as high as 0.88, which would be classified under the high category used by Rose.
The use of 100% versus 75% LOS setting may have also influenced the results for
MXE along with EPE. Through examining results and subject comments, it was
concluded that difficulty was increased when trying to reach the targets forward, forwardright, and forward left. However, previous studies discovered greater error in COG
targets back, back-left, and back-right. 3 Due to these repeated findings, NBM revised the
system to allow for attainable backward components, but they may also need to correct
problems that currently exist with forward motion.
Directional Control (DCL)
The factors that influenced EPE and MXE reliability will also impact the DCL
component, since they all examine the path that the subjects' COG travels. Directional
control compares the amount of movement in the intended direction (towards the target)
to the amount of extraneous movement (away from the target).2 Several studies have
found these components to be very closely related and combine EPE, MXE, and DCL
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into a single tenn, movement path. I ,3 A study perfonned by Liston et all found that the
movement path was reliable with an ICC of 0.84. However, according to the ICC
interpretation table a value of 0.84 would not have been clinically reliable.
Tester 1 produced clinically reliable values for DCL between trials 4 and 5 but
was unable to maintain clinical reliability for the last trial. This may also be explained by
the lack of motivation of the subjects as previously discussed. Tester 1 obtained a
negative ICC value between trials 1 and 2, as seen with the RT component. Since
negative scores were only obtained between trials 1 and 2, it may be assumed that the
subjects were not provided enough practice time to adjust for the learning curve. This
allowed for improvement between trials that can be associated with increased
understanding by the subjects and not influenced by the instruction provided by the
testers. Rose 8 suggests reliability is very high if the first trial is discarded and the second
and third trials are compared, as was utilized in the current study. However, subjects may
have needed further practice indicating the second trial should also be discarded and
comparisons should not start until the third and fourth trials. Tester 2 reached clinical
reliability between trials 5 and 6 and demonstrated consistent improvement beginning
with trials 2 and 3. Further testing is needed to examine if this level of reliability can be
maintained.
Rose 8 found the DCL component to be the least reliable of all the components on
the LOS Test with a correlation coefficient of 0.68. In the present study it was found that
Tester 1 and Tester 2 had correlation coefficients greater than 0.80 for all trials except
trials 1 and 2 for Tester 1. This indicates high reliability according to the interpretation
table used by Rose.
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Testing Trials
Past researchers have recommended that research needs to be conducted
addressing the amount of training necessary to become reliable on the NBM LOS Test.

4

It was found that clinical reliability for all the components of the LOS test on the NBM

could not be obtained with 35-42 training trials. However, when individual components
are examined, both testers were reliable on the MVL component. Tester 1 took 25-30
training trials before reaching reliability while Tester 2 reached reliability between
training trials 15-20. All other individual components were not considered reliable since
both testers did not maintain ICC values greater than 0.90 by the seventh training trial.
However, if this study's data were analyzed using the interpretation table presented in the
study by Rose 8 , reliability would have been obtained on all components.
Testing Time
An unexpected finding was discovered when the length of each testing session
was timed. Subjects became more proficient in testing procedures and required less
processing of instructions. The number of repeated tests decreased due to the subjects
increased awareness of desired outcomes, decreasing the amount of time needed to
perform the testing. A drawback to decreased testing time can be attributed to the lack of
motivation experienced during the final trials. The subjects were tired of returning for
testing and may have lost their interest in the assessment test; therefore they may not
have provided maximal effort. This further supports the decrease in reliability between
trials 5 and 6.
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Limitations and Recommendations
Although this study adds to the research on reliability of the NBM LOS Test, it is
evident that limitations exist, and the researchers have recognized them. These
limitations include small, select sample size; limited number of testers; quantity of trials;
high learning curve; calibration and software of the NBM; and structured instruction.
The use of a small sample size has brought many problems in this area of study.
In order to make references to the population, a sample size of at least 30 subjects should
be utilized.
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Due to the extended time needed for this study, a sample of convenience

was chosen to insure compliance. Subjects in this study were composed of normal,
asymptomatic individuals, which has been shown in previous studies to cause poor intrarater reliability. It has been shown that when a wider range of subjects with a variety of
performance capabilities is used, a larger variability between subjects is found. 8 An ICC
value requires a variation between subjects to be a meaningful index of reliability. 18
Therefore, it is recommended that a large sample size be utilized and a patient population
consisting of asymptomatic and impaired individuals be used for future studies.
Secondly, there were only two testers chosen for this study. This is a small
number to represent an entire population of people who may be administering the LOS
Test on the NBM. It would be recommended in future studies that more than two
individuals test a group of subjects so solid references about other NBM administrators
could be made.
Thirdly, the study design allowed for only seven trials, in which six were used to
perform statistics. With this limited number of trials, there was difficulty identifying
trends or patterns in the data. If further testing were conducted, it would either solidify
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the results and insure that reliability could be maintained or reveal that reliability was
reached by a random occurrence between specific trials. However, one has to keep in
mind that by the seventh trial in this study, the subjects were becoming unmotivated and
varying in their individual scores. This may become more evident when further trials are
administered. For a stronger outcome, it is recommended that more testing trials are
performed and that subject motivational levels remain high. This may be achieved by
selecting a larger number of subjects that are tested only once a week for up to 3 trials,
resulting in more testing trials with maintained motivation. A motivational questionnaire
following each testing trial may assist in discovering the time within the study that
motivation of the subjects changed enough to alter data collection, which would enable
the testers to modify the testing procedure. A follow-up study is also recommended
approximately 2-3 weeks after initial testing has ended to discover if reliability remains
unchanged.
A fourth limitation is the high learning curve for the subjects on the NBM.
Previous studies have suggested that reliability is high when the first trial is discarded and
the subsequent trials are compared for analysis. 8 This technique was utilized in this
study; however, it is believed but not proven that the learning curve is carried over into
the second trial and discarding it will provide more accurate results. However, this would
further extend the study, which could be a potential drawback. In this study, there were
only 5 minutes between trials 1 and 2, which may not have provided enough practice time
to eliminate the learning curve. A lengthened period of practice time may enable the
subjects to become familiar with the movements of the cursor, which would facilitate
greater reliability.
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Another limitation of this study was possible error in the calibration of the NBM
even though it automatically calibrates each time it is turned on. During the LOS Test, it
appeared that a majority of the subjects had difficulty reaching forward components.
Research has found that subjects are able to shift their COG forward to a greater extent
than they can backward. 3 Thus, it is assumed that subjects would be able to reach the
forward components easier than the backward components. The NBM has recently
updated their software to version 7.06 so that backward positions are easier to reach;
therefore, it may have made it more difficult to move towards the forward destinations.
When the subjects aligned with the computer in their neutral position, it was reported that
they felt their weight was shifted forward. This may make it difficult as well to compare
results to past studies in which different software programs were utilized. An example of
this would be the use of NBM 6.1 as used in the study by Roses versus NBM 7.06 used in
the present study.
Prior to the start of this study, the testers were provided with training on the use of
the NBM and were allotted time for practice so familiarity with the machine and test was
obtained. The study design required the testers to state a structured, pre-written set of
instructions to each subject that clearly explained the LOS Test and its expectations. The
design did not provide an opportunity for further explanation, deviation, or modification
to meet the individual subject needs. This technique was important for a structured study
so that all subjects received an equal amount of instruction. However, this did not allow
the testers to provide encouragement or further explanation when needed, which enabled
the subjects to make recurring mistakes. In the clinic, this technique would not be
utilized because treatments need to address individual patient needs. Experienced
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clinicians have already developed good communication skills and patient handling
techniques versus students, such as the testers in this study, who are still developing these
skills. Students may have an increased difficulty in detecting the individual patient needs
and accommodating for them.
Conclusion
Vital to optimal functioning and required for safety, balance is an essential
component for daily activities. There are a variety of disorders and impairments that are
associated with balance deficits that can be addressed with rehabilitation. To insure
correct evaluation and efficacy of treatment programs, it is imperative that the assessment
measure be reliable and valid. One of the many measures for testing balance is with a
computerized assessment tool such as the NBM LOS Test. The purpose of this study was
to determine the amount of training needed for a therapist to become reliable with the
NBM LOS Test for the use in both clinical and research settings.
Through this research, it was determined that a clinical level of intra-reliability for
all components of the NBM LOS Test could not be obtained with a moderate level of
tester training of 35-42 trials and prior familiarization. Out of the five components, only
MVL reached clinical reliability for both testers. The other components may have
reached good reliability but according to the guidelines of this study, were unable to
maintain clinically required values to be utilized in daily clinical practices as an
assessment tool. Nevertheless, the NBM can be used as a training device and can record
measurement of patient progression. This study did not discover the minimal amount of
training necessary to obtain clinically reliable measurements on the NBM LOS Test for
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all components. Interestingly, the data for each component in this study either met or
exceeded the intra-rater reliability requirements made by the manufacturer.
Despite the inability to prove the NBM LOS Test clinically reliable, it can still
have many benefits within the clinical realm. The results received from the NBM LOS
Test in the clinic should be interpreted with awareness and consideration of the
limitations of the device. The LOS Test may be used as an assessment in conjunction
with other functional assessment tools such as the Berg Balance Measure or the Tinetti
Assessment Tool. Considering the limitations and recommendations, further research on
this topic should be conducted to determine the actual amount of training required to
obtain clinically reliable results on the LOS Test.
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1. ABSTRACT: (LIMIT TO 200 WORDS OR LESS AND INCLUDE JUSTIFICATION OR NECESSITY FOR USING HUMAN
SUBJECTS.)

Balance is critical for optimal function in completion of everyday tasks. It is necessary to have good
balance in order to get out of bed, walk, and complete occupational duties. Physical therapists
frequently work with people that have balance disturbances in order to help return them to optimal
function. One tool used in the assessment and treatment of balance disturbances is the
NeuroCom® Balance Master System 7.06. The system consists of a forceplate connected to a
computer. Force sensors measure forces exerted by the patient's feet and send these
measurements to the computer to be analyzed. It is essential that the therapist is reliable in
obtaining measurements from the NeuroCom® Balance Master. The purpose of this study is to
determine the amount of training needed for a therapist to become reliable with the NeuroCom®
Balance Master in both clinical and research settings. In order to establish reliability, it is necessary
to use human subjects to determine the number of subjects a therapist must test before he/she
develops high intra-rater reliability. Research has shown the NeuroCom® Balance Master to be
reliable but none has shown the amount of training the therapist should have to obtain this reliability.

PLEASE NOTE: Only information pertinent to your request to utilize human subjects in your project or activity should be
included on this form . Where appropriate attach sections from your proposal (if seeking outside funding).
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2. PROTOCOL: (Describe procedures to which humans will be subjected. Use additional pages if necessary. Attach any
surveys, tests, questionnaires, interview questions, examples of interview questions (if qualitative research),
etc., the subjects will be asked to complete.)

Subjects: Subjects will include up to 50 healthy individuals ranging from the ages of 20 to 59 years
old. Researchers will recruit subjects by word of mouth from the Grand Forks community and the
UNO population. Involvement in the study will be voluntary and informed consent will be obtained
through a signed consent form before any testing or training procedures will be performed. Subjects
will be excluded from this study if they have a current or past medical condition or are taking
medications that affect balance. The subject will be required to complete a Health Background
Questionnaire to determine eligibility.
Testing Procedure: Balance will be measured and utilized to determine the intra-rater reliability using
the NeuroCom® Balance Master limits of stability assessment test. The NeuroCom® Balance Master
is a clinically acceptable and safe machine commonly used in physical therapy to assess balance. A
computer software program will collect and interpret data from the forceplates on which subjects
stand. The computer screen is equipped with a cursor to provide visual feedback on the location of
the subjects' center of gravity. The subjects' dynamic balance will be assessed with the limits of
stability test using standardized testing procedures. The subjects control the cursor by leaning
quickly and accurately so the cursor moves towards targets that are displayed on the computer
screen. This test requires subjects to maintain their balance while weight shifting in all directions with
feet planted on the forceplate. Subjects will be required to remove socks and shoes during testing
procedures. Testing will be performed by one of the researchers at the University of North Dakota
Physical Therapy Department. The preceptor will supervise the study.
At the initial assessment subjects will be given instructions on testing procedures and be allowed to
practice. Subjects will then perform the limits of stability balance assessment. This trial will be
recorded but not analyzed due to the high learning curve as suggested by previous research.
Immediately following the first trial, a second trial will be recorded and the data from this trial will be
analyzed for research. Subsequent trials will be performed every 3-7 days for up to five additional
trials, until reliability is achieved. At each subsequent trial (2,3,4,5 or 6), subjects will complete a
Current Health Status Questionnaire upon arrival for testing. A "warm up" session will be allowed
followed by one limits of stability balance assessment trial. This trial will be recorded and analyzed to .
determine reliability. Data will be collected for up to a total of six sessions. The Pearson r correlation
coefficient or the interclass correlation coefficient (ICC) will be used to compare trial one to trial two,
trial two to trial three, etc until a high level of correlation is determined. A high level of reliability for
this study is defined as r = 0.80 or ICC = 0.90. If reliability is not reached in six sessions, it will be
determined that reliability cannot be reached.
Data Analysis and Recording: Traditional descriptive and analytical statistics will be used to analyze
the data. The individuals' results will remain confidential and the data will be identified by a number
known only to the researchers. To ensure maximum confidentiality data will be kept in a locked office
in the University of North Dakota Physical Therapy Department for three years following completion of
this study. After three years the data will be destroyed.
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3. BENEFITS: (Describe the benefits to the individual or society.)

The primary goal of this study is to determine the amount of training needed to obtain intra-rater reliability
when using the NeuroCom® Balance Master to test balance in a clinical or research setting. This will
allow physical therapists to provide more accurate balance assessment and training. Subjects may
benefit from exposure to the research process and the knowledge that they are helping to improve the
field of physical therapy. In addition, the subjects may gain knowledge of their own balance abilities from
participating in this study.
4. RISKS: (Describe the risks to the subject and precautions that will be taken to minimize them. The concept of risk goes
beyond physical risk and includes risks to the subject's dignity and self-respect, as well as psychological, emotional
or behavioral risk. If data are collected which could prove harmful or embarrassing to the subject if associated with
him or her, then describe the methods to be used to protect the confidentiality of data obtained, debriefing
procedures, storage of data, how long date will be stored (must be a minimum of three years), final disposition of
data, etc.)

The risks associated with this study are minimal, but those that do exist will be controlled. Possible risks
include loss of balance and/or falls. These risks will be minimized through proper instructions and
supervision with a spotter throughout testing procedures. Verbal instructions will be provided prior to
assessment on the NeuroCom® Balance Master to ensure safety.
In the event that this research activity results in a physical injury, medical treatment will be as available
as it is to a member of the general public in similar circumstances. The University of North Dakota and
the researchers are not responsible for any such injury or treatment. Payment for any such treatment
must be provided by you and your third party payer, if any.
Respect for the individual will be ensured by informing the subjects that all information will be kept
confidential. Confidentiality will be maintained through using assigned numbers and not attaching the
subjects' names to the reported data. Subjects will be scheduled to maintain privacy and safety.
Subjects will be informed of their right to withdraw from the study at any time via the consent form signed
prior to participation in this study.
5. CONSENT FORM: Attach a copy of the CONSENT FORM to be signed by the subject (if applicable) and/or any statement to
be read to the subject should be attached to this form . If no CONSENT FORM is to be used, document
the procedures to be used to assure that infringement upon the subject's rights will not occur.
Describe where signed consent forms will be kept and for how long (must be a minimum of 3 years),
including plans for final disposition or destruction.

Informed consent will be obtained through the attached consent form. Each subject will be required to
sign the form signifying his or her agreement with the terms presented. Only the researchers will be
allowed access to the consent forms and data collected which will be kept in separate locked cabinets in
a locked office at the University of North Dakota Department of Physical Therapy. Information will be
kept for a period of three years following the completion of this study and after that time will be destroyed
using a paper shredder.
6. For FULL IRB REVIEW forward a signed original and fifteen (15) copies of this completed form, including fifteen (15) copies
of the proposed consent form, questionnaires, examples of interview questions, etc. and any supporting documentation to the
address below. An original and 19 copies are required for clinical medical projects. In cases where the proposed work is part
of a proposal to a potential funding source, one copy of the completed proposal to the funding agency (agreement/contract if
there is no proposal) must be attached to the completed Human Subjects Review Form if the proposal is non-clinical; 7 copies
if the proposal is clinical medical. If the proposed work is being conducted for a pharmaceutical company, 7 copies of the
company's protocol must be provided.
Office of Research & Program Development
University of North Dakota
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Grand Forks, North Dakota 58202-7134
On campus, mail to: Office of Research & Program Development, Box 7134, or drop it off at Room 105 Twamley Hall.
For EXEMPT or EXPEDITED REVIEW forward a signed original, including a copy of the consent form, questionnaires,
examples of interview questions, etc. and any supporting documentation to one of the addresses above. In cases where the
proposed work is part of a proposal to a potential funding source, one copy of the completed proposal to the funding agency
(agreement/contract if there is no proposal) must be attached to the completed Human Subjects Review Form.

The policies and procedures on Use of Human Subjects of the University of North Dakota apply to all activities involving use of
Human Subjects performed by personnel conducting such activities under the auspices of the University. No activities are to be
initiated without prior review and approval as prescribed by the University's policies and procedures governing the use of human
subjects.

SIGNATURES:

Principal Investigator

Date

Project Director or Student Adviser

Date

Training or Center Grant Director

Date

(Revised 2/2000)
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STUDENT RESEARCHERS: As of June 4, 1997 (based on the recommendation of
UND Legal Counsel) the University of North Dakota IRB is unable to approve your
project unless the following "Student Consent to Release of Educational Record" is
signed and included with your "Human Subjects Review Form."

STUDENT CONSENT TO RELEASE OF EDUCATIONAL RECORD

1

Pursuant to the Family Educational Rights and Privacy Act of 1974, I hereby consent to
the Institutional Review Board's access to those portions of my educational record
which involve research that I wish to conduct under the Board's auspices. I understand
that the Board may need to review my study data based on a question from a
participant or under a random audit. The study to
which this release pertains is

Examination of Tester Reliability Utilizing the Limits of Stability Test

on the NeuroCom® Balance Master for Assessing Balance in Healthy Individuals

I understand that such information concerning my educational record will not be
released except on the condition that the Institutional Review Board will not permit any
other party to have access to such information without my written consent. I also
understand that this policy will be explained to those persons requesting any
educational information and that this release will be kept with the study documentation.

Date

Signature of Student Researcher

1Consent required by 20 U.S.C. 1232g.
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REPORT OF ACTION: EXEMPT/EXPEDITED REVIEW
University of North Dakota Institutional Review Board
Date: May 4, 2001

Project Number:

Name: Casey Bartolo, Katie Miller, Rachael Seals, Christal Stotesbery
Project Title:

IRB-200105-236

--~~~~~~~--------

Department/College: Physical Therapy

Examination of Tester Reliability Utilizing the Limits of Stability Test on the NeuroCom® Balance
Master for Assessing Balance in Healthy Individuals

.,

The above referenced project was reviewed by a designated member for the University's Institutional Review Board
on
5 - ( - c \
and the following action was taken:

D

Project approved. EXPEDITED REVIEW Category No. _____________________________________
Next scheduled review is on:
The attached consent fonn dated ________________________ is the only consent form

D

which may be used for this study.

Q

LI

/Project approved. EXEMPT REVIEW Category No.
This approval is valid until
2u c~ 'I' /} GJ l-·,-:).-~----------a-s--Io-n-g-a-s-a-p-pr-o-v-ed--p-ro-ce-du-r-e-s-a-re-followed. No periodic review scheduled Jnless so stated in the Remarks Section.
~

The attached consent fonn dated
which may be used for this study.

May 7! 2001

is the only consent fonn

-

D

Project approved PENDING receipt of corrections/additions. These corrections/additions should be submitted
to ORPD for review and approval. This study may NOT be started UNTIL final IRB approval has been
received. (See Remarks Section for further infonnation.)

D

Project approval deferred. This study may not be started until finallRB approval has been received.
(See Remarks Section for further infonnation.)

D

Project denied. (See Remarks Section for further infonnation.)

REMARKS: Any changes in protocol or adverse occurrences in the course of the research project must be
reported immediately to the IRB Chairperson or ORPD.
PLEASE NOTE: Requested revisions for student proposals MUST include adviser's signature. All revisions
MUST be highlighted.

:;;' . 7 -

cc: Meridee Danks, Adviser

Signature of Designated IRB Member
UND's Institutional Review Board

c:' [

Date

If the proposed project (clinical medical) is to be part of a research activity funded by a Federal Agency, a special
assurance statement or a completed 310 Fonn may be required. Contact ORPD to obtain the required documents.
(Revised 212001)
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APPENDIXB

APPROVED BY
MAY v'7 2001
Jniversity of North Dakota
Institutional Review Board

Consent Form

Title: Examination of Tester Reliability Utilizing the Limits of Stability Test on the
NeuroCom® Balance Master for Assessing Balance in Healthy Individuals
You are invited to participate in a study conducted by students of the University of North
Dakota Physical Therapy Program, Casey Bartolo, Katie Miller, Rachael Seals and
Christal Stotesbery, in collaboration with faculty member, Meridee Danks. The purpose
of this study is to determine the amount of tester training necessary to accurately assess
balance using the NeuroCom® Balance Master. The NeuroCom® Balance Master is a
machine commonly used to test balance in a physical therapy setting. Subjects for the
study must be healthy individuals between the ages of 20-59. All volunteers in this age
group will be eligible for the study unless there is a safety or health concern excluding
you from the study. You will be asked to complete a brief health questionnaire prior to
participation in the study to ensure your safety. You will be asked to wear loose,
comfortable clothing and will be barefoot during all balance testing.
Your participation in the study will involve assessment on the NeuroCom® Balance
Master. Testing will last approximately 15-30 minutes each session for up to 6 testing
sessions. Total duration of the study will be approximately 4-6 weeks with sessions
being held 3-7 days apart. The testing will include leaning forward, backward, sideways
and diagonally without moving your feet. The first session will include a "warm up"
session and a practice trial assessment lasting for approximately 10-15 minutes followed
by performance of the actual assessment test. Each follow-up test will begin with a
"warm up" session to become reoriented to the machine.
Although the process of balance assessment involves some risk of falling or injury,
researchers feel the risk is minimal. Risk will be minimized through proper instructions
and supervision with a spotter throughout testing procedures. If you choose to participate
in this study you will benefit from involvement in a research setting and the knowledge
that you will be helping to improve the field of physical therapy. You may also benefit
from gaining knowledge of your own balance abilities.
The results of this study will remain confidential and your data will be identified by a
number known only to the researchers. This consent form and your results will be kept in
separate locked cabinets in a locked office in the Physical Therapy Department at the
University of North Dakota for three years following completion of the study. After this
period of time, your results will be destroyed. Your decision whether or not to participate
will not change your future relations with the University of North Dakota or the Physical
Therapy Department. If you decide to participate, you are free to discontinue
participation at any time without it being held against you. If it is determined that you
have a health condition that may put you at risk for injury you may be excluded from the
study. Again you will not be penalized in any way.
The researchers will be available to answer any current or prospective questions you may
have concerning this study. Questions may be answered by calling Katie or Rachael at
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(701) 777-5722, Christal at (701) 777-8101 or Casey at (701) 795-9028. At your request,
a copy of this consent form will be provided to you for future reference. If you would
like to contact the advisor, Meridee, she can be reached at (701) 777-3861.
In the event that this research activity results in a physical injury, medical treatment will
be as available as it is to a member of the general public in similar circumstances. The
University of North Dakota and the researchers are not responsible for any such injury or
treatment. Payment for any such treatment must be provided by you and your third party
payer, if any.

ALL OF MY QUESTIONS HA VE BEEN ANSWERED AND I AM
ENCOURAGED TO ASK ANY QUESTIONS THAT I MAY HA VE
CONCERNING THIS STUDY IN THE FUTURE. I HA VE READ ALL OF THE
ABOVE AND MY SIGNATURE BELOW INDICATES MY WILLINGNESS TO
PARTICIPATE IN THIS STUDY EXPLAINED TO ME BY CASEY BARTOLO,
KATIE MILLER, RACHAEL SEALS AND CHRISTAL STOTESBERY.

Participant's Signature

Date

Date

Witness

APPROVED BY
MAY 07 2001
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University of North Dakota
Institutional Review Board

APPENDIXC

Subject: _ _ _ _ __
Date: _ _ _ _ _ _ __
Practice Time: _ _ _ __
Practice Trial: _ _ _ __
Test Trial: _ _ _ _ __

Health Background Questionnaire
1. Do you have any current or past medical diagnosis or injury that affects your
balance? (i.e. recent fractures or surgery, inner ear infections) If so, please
describe.

2. Are you currently taking any medications? Please list all over the counter and
prescription medications so we can determine if these may affect your balance.

3. Do you currently have any symptoms of dizziness or lightheadedness?

4. Have you been diagnosed with any psychological conditions (i.e. depression)?

5. Have you had two or more unexplained falls within the last 6 months?

6. Do you have normal vision with or without glasses/contact lenses?

7. Have you previously been tested on the Balance Master?
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Subject: _ _ __
Trial # : _ _ _ __
Date: ______
Practice Time: - - Test Time: _ _ __

Current Health Status Questionnaire
Has anything happened since the last assessment that may have affected your balance?
(i.e. falls, change in medications, ear infections, illness, injury). Briefly describe below.

Do you have any comments or concerns before continuing the Balance Master
assessment?
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APPENDIXD

Name: Smith, Joe
ID: ATIDOO074
Date of Birth: 31711978
Comments:
Height: 5'4"

Diagnosis: Not Specified
Operator: Not,Specified
Referral Source: Not Specified

File: FD74.DRX
Date: 10/1/2001
Time: 10:55:17
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NeuroCom System Version 7.0.6, Copyright ©1989-2000 NeuroCom® Intemationallnc. All Rights Reserved.

APPENDIXE

Verbal Instructions for Subjects:
Limits of Stability

Pretest Instructions:
Stand with both feet on the Balance Master. Eight targets will appear on the screen
surrounding a center target. Begin by centering the entire cursor (the image of a person)
in the middle target and hold it there. As you shift your weight the cursor on the screen
will move in the same direction. You are allowed to use your arms and shift your hips as
much as you would like, but you must not move your feet. Both feet must maintain
contact with the forceplate throughout testing. Do not lift your heels from the forceplate.
A blue circle will appear in one of the targets indicating you should move in that
direction. As soon as the blue circle appears in the yellow outer target, move your cursor
as quickly, accurately, and as far as you can towards the yellow target containing the blue
circle. Hold the cursor there as long as the blue circle remains. When each trial is
finished, hold the cursor motionless in the center target until the next trial begins. This
procedure will be repeated for all eight targets.

Test Instructions:
Hold the cursor in the center target until the blue circle appears in the target that you will
move to, then move the cursor as straight and as quick as possible and hold it in box #_.
Are you ready?
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